EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

Sivapar V Mathan iD, Rana P Singh iD

Cancers · 23.06.2025 · 17 (13) · 2100

DOI: 10.3390/cancers17132100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.06.2025. Verfasst von Sivapar V Mathan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 359 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Drugs & Pharmaceutical Research programme—Department of Science & Technology (DPRP-DST), Government of India, Indian Council of Medical Research (ICMR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer continues to pose a significant challenge to global health, resulting in millions of deaths annually despite advancements in treatments like surgery, chemotherapy, and radiotherapy. A key factor complicating successful outcomes is the presence of cancer stem cells (CSCs), which possess distinctive features that facilitate tumor initiation and progression as well as resistance to therapies. These cells are adept at evading conventional treatments and can hinder the effectiveness of immunotherapy, often manipulating the tumor microenvironment to suppress immune responses. This review delves into the complex interplay between CSCs and immune cells, emphasizing their contributions to tumor heterogeneity and therapeutic resistance. By investigating the CSC niche in which these cells thrive and their complex interactions with the immune system, we aim to reveal new therapeutic avenues that could enhance patient outcomes and minimize the risk of recurrence. CSCs are characterized by remarkable self-renewal and plasticity, allowing them to transition between stem-like and differentiated states in response to various stimuli. Their existence within the CSC niche confers immune protection and maintains stem-like properties while promoting immune evasion. Activating key signaling pathways and specific surface markers is crucial in developing CSC traits, pointing to potential strategies for effective tumor eradication. Conventional therapies often fail to eliminate CSCs, which can lead to tumor recurrence. Therefore, innovative immunotherapeutic strategies such as dendritic cell vaccines (DC vaccines), chimeric antigen receptor (CAR) engineered T cells, and immune checkpoint inhibitors (ICIs) are under examination. This review sheds light on CSC’s roles across different malignancies, highlighting the necessity for innovative targeted approaches in cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

CSC nichecancer stem cells (CSCs)immune evasionimmunotherapytumor microenvironment (TME)

Autor:innen und Institutionen

  • Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
  • Department of Biotechnology, Gautam Buddha University, Greater Noida 201312, India.
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.

ORCID-Profile: Sivapar V Mathan, Rana P Singh

Förderung

  • Drugs & Pharmaceutical Research programme—Department of Science & Technology (DPRP-DST)
  • Government of India
  • Indian Council of Medical Research (ICMR)

Zitieren

APA

Mathan, S. V., & Singh, R. P. (2025). Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities. Cancers, 17(13), 2100. https://doi.org/10.3390/cancers17132100

Vancouver

Mathan SV, Singh RP. Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities. Cancers. 2025;17(13):2100. doi:10.3390/cancers17132100

BibTeX
@article{Mathan2025,
  author = {Mathan, Sivapar V and Singh, Rana P},
  title = {Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2100},
  doi = {10.3390/cancers17132100}
}
Kostenlos starten →